Clinical Trial Update: A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 trial of LY3471851 in adults with moderately to severely active ulcerative colitis was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LY3471851

Snippet

Sponsor: Nektar Therapeutics | Conditions: Colitis, Ulcerative | Phase 2 | Status: TERMINATED | Results posted: 2023-09-05